Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar shirtface (< 20) Submitted: 8/9/2011 6:39:02 PM : Outperform Start Price: $26.07 BMY Score: +12.30

Nice dividend return...

Report this Post Reply

Featured Broker Partners


Advertisement